IL204100A - Nucleic acid sequences comprising nf-kb binding site within o(6)-methylguanine-dna-methyltransferase (mgmt) promoter region and uses thereof for the treatment of cancer and immune-related disorders - Google Patents

Nucleic acid sequences comprising nf-kb binding site within o(6)-methylguanine-dna-methyltransferase (mgmt) promoter region and uses thereof for the treatment of cancer and immune-related disorders

Info

Publication number
IL204100A
IL204100A IL204100A IL20410010A IL204100A IL 204100 A IL204100 A IL 204100A IL 204100 A IL204100 A IL 204100A IL 20410010 A IL20410010 A IL 20410010A IL 204100 A IL204100 A IL 204100A
Authority
IL
Israel
Prior art keywords
mgmt
methylguanine
methyltransferase
immune
dna
Prior art date
Application number
IL204100A
Other languages
Hebrew (he)
Other versions
IL204100A0 (en
Inventor
Iris Lavon
Original Assignee
Hadasit Med Res Service
Iris Lavon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2008/001169 external-priority patent/WO2009027978A1/en
Application filed by Hadasit Med Res Service, Iris Lavon filed Critical Hadasit Med Res Service
Priority to IL204100A priority Critical patent/IL204100A/en
Publication of IL204100A0 publication Critical patent/IL204100A0/en
Publication of IL204100A publication Critical patent/IL204100A/en

Links

IL204100A 2007-08-30 2010-02-22 Nucleic acid sequences comprising nf-kb binding site within o(6)-methylguanine-dna-methyltransferase (mgmt) promoter region and uses thereof for the treatment of cancer and immune-related disorders IL204100A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL204100A IL204100A (en) 2007-08-30 2010-02-22 Nucleic acid sequences comprising nf-kb binding site within o(6)-methylguanine-dna-methyltransferase (mgmt) promoter region and uses thereof for the treatment of cancer and immune-related disorders

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US96905707P 2007-08-30 2007-08-30
US96922507P 2007-08-31 2007-08-31
PCT/IL2008/001169 WO2009027978A1 (en) 2007-08-30 2008-08-28 NUCLEIC ACID SEQUENCES COMPRISING NF-ϰB BINDING SITE WITHIN O(6)-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE-RELATED DISORDERS
IL204100A IL204100A (en) 2007-08-30 2010-02-22 Nucleic acid sequences comprising nf-kb binding site within o(6)-methylguanine-dna-methyltransferase (mgmt) promoter region and uses thereof for the treatment of cancer and immune-related disorders

Publications (2)

Publication Number Publication Date
IL204100A0 IL204100A0 (en) 2011-07-31
IL204100A true IL204100A (en) 2015-05-31

Family

ID=44672015

Family Applications (1)

Application Number Title Priority Date Filing Date
IL204100A IL204100A (en) 2007-08-30 2010-02-22 Nucleic acid sequences comprising nf-kb binding site within o(6)-methylguanine-dna-methyltransferase (mgmt) promoter region and uses thereof for the treatment of cancer and immune-related disorders

Country Status (1)

Country Link
IL (1) IL204100A (en)

Also Published As

Publication number Publication date
IL204100A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
IL237658A0 (en) Gene therapy for spinal cord disorders
HK1132302A1 (en) Micrornarna-based methods and compositions for the diagnosis and treatment of solid cancers rna
EP2125855A4 (en) Methods and compositions for the treatment of cancer or other diseases
SI2029742T1 (en) Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
EP2028492A4 (en) Tumor marker and method for determination of the occurrence of cancerous disease
PL2066791T3 (en) Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
WO2007035771A3 (en) Modulation of glucagon receptor expression
EP2083843A4 (en) Multifunctional carriers for the delivery of nucleic acids and methods of use thereof
EP1867640A4 (en) Agent for treatment of solid tumor
IL195771A0 (en) Methods and immune modulatory nucleic acid compositions for preventing and treating disease
EP2046394A4 (en) Use of nucleic acid sequences for the treatment of neurological and psychiatric diseases, vectors and compositions
WO2006066154A3 (en) Casein kinase 2 antisense therapy
EP1904088A4 (en) Compositions and methods for the treatment of cancer
IL204100A0 (en) NUCLEIC ACID SEQUENCES COMPRISING NF - kB BINDING SITE WITHIN O (6)-METHYLGUANINE - DNA -METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE - RELATED DISORDERS
IL226363A0 (en) Compounds and methods for the treatment of cancer
IL185900A0 (en) Compositions and methods for the diagnosis and treatment of tumor
SI1879623T1 (en) Gene therapy for spinal cord disorders
ZA200706159B (en) Compositions and methods for the diagnosis and treatment of tumor
ZA200706871B (en) Treatment of metastasized tumors
EP1904648A4 (en) Method for localization of nucleic acid associated molecules and modifications
IL255035A0 (en) Gene therapy for spinal cord disorders
AU2006201588A1 (en) The use of all tumour supressor genes found in specific tissue in the treatment of cancer
ZA200710321B (en) Compositions and methods for the diagnosis and treatment of tumor
GB0620693D0 (en) Composition and methods for the treatment of degenerative disease
ZA201000400B (en) Methods and compositions for the treatment of cancer, tumors, and tumor related disorders

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed